Esomeprazole and omeprazole might boost the serum concentrations of benzodiazepines (via CYP2C19 inhibition) resulting in amplified adverse effects including drowsiness, although the clinical relevance is very low in many sufferers – observe the affected person for adverse effects (e.If affected person cannot resume their standard oral medication